The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
If you’re running trials in the following target indications:
- Breast Cancer
- Cholangiocarcinoma
- Colorectal Cancer
- Glioblastoma
- Non-Small Cell Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Small Cell Lung Cancer
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Diffuse Large B-Cell Lymphoma
- Multiple Myeloma
Medidata’s patient-level historical trial data can optimize your trial’s design and evidence generation. We’ve helped clients across oncology with our unique clinical trial repository data – and we are ready to show you how.
